default author photo

Thomas Hueso

University of Paris-Saclay - Department of Hematology

Villejuif

France

SCHOLARLY PAPERS

3

DOWNLOADS

211

TOTAL CITATIONS

1

Scholarly Papers (3)

1.

Infectious Complications in Patients Treated with T-Cell Engager for Solid Tumours or Haematological Malignancies, a Descriptive Study from the REISAMIC Registry

Number of pages: 33 Posted: 12 Nov 2024
University of Paris-Saclay - Department of Hematology, Gustave Roussy, Gustave Roussy, Gustave Roussy, University of Paris-Saclay - Institut Pasteur, Gustave Roussy - Hematology Department, Gustave Roussy - Hematology Department, Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy, Comité de Pathologies Thoraciques, Université Paris Saclay - Department of Children and Adolescents Oncology, Department of Pediatric and Adolescent Oncology, Institut Gustave Roussy, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy, Gustave Roussy, Aix Marseille Université, Gustave Roussy, University of Paris-Saclay, Gustave Roussy - Drug Development Department (DITEP) and Gustave Roussy - Drug Development Department (DITEP)
Downloads 115 (621,896)

Abstract:

Loading...

T-cell engager, infections, haematological malignancy, solid tumour

2.

Convalescent Plasma Improves Overall Survival in Patients with B-Cell Lymphoid Malignancies and COVID-19:  A Longitudinal Cohort and Propensity Score Analysis

Number of pages: 37 Posted: 03 Nov 2021
University of Paris-Saclay - Department of Hematology, Assistance Publique-Hôpitaux de Paris - Infectious Diseases Department, Sorbonne University - INSERM, Assistance Publique-Hôpitaux de Paris - Infectious Diseases Department, Assistance Publique-Hôpitaux de Paris - Infectious Diseases Department, Assistance Publique-Hôpitaux de Paris - Infectious Diseases Department, Assistance Publique-Hôpitaux de Paris - Infectious Diseases Department, Hôpital André Mignot - Department of Hematology, Assistance Publique-Hôpitaux de Paris - Infectious Diseases Department, Aix-Marseille University - Etablissement Français du Sang (EFS), Aix-Marseille University - Etablissement Français du Sang (EFS), Aix-Marseille University - Etablissement Français du Sang (EFS), Aix-Marseille University - Etablissement Français du Sang (EFS), Hôpital André Mignot - Department of Hematology, Assistance Publique-Hôpitaux de Paris - Department of Hematology, CHU de Montpellier - Department of Hematology, University of Paris - Laboratory of Molecular Mechanisms of Hematologic Disorders and Therapeutic Implications, University of Saint Etienne - Department of Hygiene and Infectious Diseases, Hospices Civils de Lyon - Pneumology Department, Sorbonne University - Institut Pierre Louis d'Épidémiologie et de Santé Publique IPLESP, Sorbonne University - Institut Pierre Louis d'Épidémiologie et de Santé Publique IPLESP and affiliation not provided to SSRN
Downloads 61 (961,006)
Citation 1

Abstract:

Loading...

Convalescent plasma, COVID-19, Hematological malignancies, Anti-CD20, B-cell deficiency

3.

Feasibility and clinical relevance of the G-CODE in older adults treated in Phase 1 Clinical Trials at Gustave Roussy

Number of pages: 15 Posted: 15 Oct 2025
Gustave Roussy - Drug Development Department (DITEP), affiliation not provided to SSRN, Gustave Roussy, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy, University of Paris-Saclay - Department of Hematology, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy, Université Paris XI Sud - Gustave Roussy Cancer Campus, Gustave Roussy - Drug Development Department (DITEP) and Gustave Roussy
Downloads 35 (1,263,436)

Abstract:

Loading...

G-CODE, geriatric assessment, phase 1 clinical trials, older adults, feasibility, Toxicity